Inotropic agent combination

This page covers all Inotropic agent combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adrenergic receptors (alpha-1, beta-1) and cardiac troponin C.

Targets

Adrenergic receptors (alpha-1, beta-1) and cardiac troponin C

Marketed (1)

• epinephrine and levosimendan · Federal University of Juiz de Fora · Cardiovascular
  This combination uses epinephrine's alpha and beta-adrenergic stimulation alongside levosimendan's calcium sensitization to enhance cardiac contractility and improve hemodynamics in acute heart failure.

Patent intelligence

• inotropic agent combination patent landscape — aggregated cliff calendar, attackable patents, originator estates